{"id":3668,"date":"2025-05-20T01:22:00","date_gmt":"2025-05-20T06:22:00","guid":{"rendered":"https:\/\/mickeylieberman.com\/parkinsons\/?p=3668"},"modified":"2025-03-07T09:52:29","modified_gmt":"2025-03-07T14:52:29","slug":"parkinsons-disease-and-your-chances-of-developing-it","status":"publish","type":"post","link":"https:\/\/mickeylieberman.com\/parkinsons\/parkinsons-disease-and-your-chances-of-developing-it\/","title":{"rendered":"Parkinson&#8217;s Disease And Your Chances of Developing it"},"content":{"rendered":"<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Parkinson&#8217;s Disease\u00a0 <\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Considering that Parkinson&#8217;s Disease patients vary considerably with regards to symptoms or signs they encounter and their response to medication, the facts available for the condition are variable and differ depending on the study in question.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Also, the data collected on Parkinson&#8217;s from certain parts of the planet, especially in less technologically developed nations, is patchy or unverifiable.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">This makes deriving precise and meaningful Parkinson&#8217;s disease stats for such countries, as well as about issues such as race and Parkinson&#8217;s disease, problematic.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">As a general guide, Parkinson&#8217;s appears to affect around 0.2%-0.3% of the general population and appears to affect seniors more frequently, with about 90% of documented cases being diagnosed in those over sixty years of age.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Some 3% to 5% of individuals over sixty-five will develop Parkinson&#8217;s.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Less than 10% of new cases of Parkinson&#8217;s are diagnosed in adults under the age of 40.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Some research suggests an increased risk of the disease happening between sixty and seventy-five years of age, but that the risk would seem to decline significantly after this age, especially after age eighty-five.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Truth be told, Parkinson&#8217;s is virtually never found in the &#8216;super old&#8217;, meaning those aged over 100.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">However, potential misdiagnosis at this point represents a real concern because of the lack of a definitive biological marker for diagnosing Parkinson&#8217;s.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">It has been suggested that the number of individuals over age 60 who should be clinically diagnosed as suffering from some kind of Parkinsonism, is considerably greater than is currently acknowledged.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">For example, some studies have implied that those with mild Parkinson-like symptoms (which could be indicative of early stage Parkinson&#8217;s disease or possible due to other conditions or diseases) may be as high as fifteen percent in the age group 60-74 and 30% for anyone between 75-84 years old.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Whatever the true number, because of an ever increasing world population combined with an upward trend for life expectancy, the number of anticipated cases of Parkinson&#8217;s in future generations is bound to increase greatly.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">For example, some research has suggested that the percentage will double during the next 40 years.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Whilst we have discussed Parkinson&#8217;s and the aspect of age, can one observe differences in the chance of developing the condition based upon race, hereditary, and gender?<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">For anyone who has relatives who developed Parkinson&#8217;s disease when they were seniors, the elevated risk to them of developing the condition would seem insignificant.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">However, opinions do differ on this matter.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Some studies have suggested that if a close relation has\/had the disease, the total heightened threat of developing Parkinson&#8217;s is approximately two to five percent and possibly as much as fifteen percent in the most severe case.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Regarding the question of gender, data yet again varies notably between sources.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Some studies have implied that men seem to be at double the risk of Parkinson&#8217;s disease than women.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Support for this comes from statistics that indicate women who have had hysterectomies have a higher rate of Parkinson&#8217;s disease, and women who&#8217;ve had estrogen replacement therapy have a lower risk of Parkinson&#8217;s disease compared to other women their age.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The assumption is that oestrogen may play a function in protecting the body from the chemical changes which occur in Parkinson&#8217;s disease.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Several investigations have suggested there&#8217;s no difference between genders or that the figure represents approximately a 50% increased risk for men.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Additionally, it has been noted that the disease progresses more quickly in males and that men tend to be more likely to experience tremor and rigidity, whereas women tend to be at more danger of gait disturbances and shuffling.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The truth is that common agreement concerning this issue has not yet been obtained.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The figures available on the matter of race and Parkinson&#8217;s risk are yet again variable.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">For example, certain research indicates there is no difference whereas others suggest that Caucasians have an increased danger of Parkinson&#8217;s compared to either Asian Americans or African Americans.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">In addition, a few studies have noted that people of European ancestry appear most predisposed to typical Parkinson&#8217;s, whereas non-Caucasians may be at greater risk from a certain type of non-typical Parkinson&#8217;s, associated with judgment dysfunction.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The issue is further clouded with other research observing that where variations are noted, there would seem to be no distinction between race groups from comparable locations.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">Apart from Race, Age, Hereditary, Gender factors, the question of environmental variables such as pesticides and toxins are deserving of consideration.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">It appears that these are likely involved in the potential for individuals aged over 50 years of age.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">In addition, there seem to be other possible factors which unfortunately have an impact on increasing the risk of developing Parkinson&#8217;s disease.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">For instance, exposure to certain bacteria and viruses, or due to suffering head injuries or trauma.<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">The complexity of the condition is highlighted further by the intriguing statistics from some research that indicate that individuals who drink coffee or smoke frequently are at reduced risk of developing Parkinson&#8217;s!<\/span><\/p>\n<p><span style=\"font-family: verdana, geneva, sans-serif; font-size: 14pt;\">A hub for individuals living with or having to deal with Parkinson&#8217;s disease, including details on the signs and symptoms, potential factors and statistics, causes, stages, prognosis, medical treatments and latest news about the condition.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parkinson&#8217;s Disease\u00a0 Considering that Parkinson&#8217;s Disease patients vary considerably with regards to symptoms or signs they encounter and their response to medication, the facts available&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"slim_seo":{"title":"Parkinson's Disease And Your Chances of Developing it - Parkinson&#039;s Disease","description":"Parkinson's Disease\u00a0 Considering that Parkinson's Disease patients vary considerably with regards to symptoms or signs they encounter and their response to medi"},"_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3668","post","type-post","status-publish","format-standard","hentry","category-parkinsons","wpcat-1-id"],"_links":{"self":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/posts\/3668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/comments?post=3668"}],"version-history":[{"count":0,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/posts\/3668\/revisions"}],"wp:attachment":[{"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/media?parent=3668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/categories?post=3668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mickeylieberman.com\/parkinsons\/wp-json\/wp\/v2\/tags?post=3668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}